MedTrace Logo

Dose Adjustment of Tacrolimus Based on Home Sampling in Renal Transplant Recipients

NCT03512431 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 27

Last updated 2019-08-28

No results posted yet for this study

Summary

Repeated 12-hour pharmacokinetic (PK) investigations in renal transplant recipients for parallel sampling of standard venous bloods samples and finger prick micro samples (Mitra tips). Primary aim to validate the micro sampling tacrolimus concentrations against venous blood concentrations.

Conditions

  • Renal Transplant Rejection

Interventions

DIAGNOSTIC_TEST

Micro sampling

Compare finger prick micro samples with venous blood samples for measuring whole blood tacrolimus concentrations

Sponsors & Collaborators

  • Sandoz

    collaborator INDUSTRY

  • The Norwegian association for renal disease and transplants

    collaborator UNKNOWN

  • Oslo University Hospital

    lead OTHER

Principal Investigators

  • Karsten Midtvedt, MD, PhD · Oslo University Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-04
Primary Completion
2018-11-01
Completion
2018-11-01

Countries

  • Norway

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03512431 on ClinicalTrials.gov